We measured blood concentrations of heroin and its active metabolites, 6-acetylmorphine and morphine, serially in 11 patients with chronic pain (9 of whom had cancer) after intravenous injection, intravenous infusion, intramuscular injection, and an oral dose of heroin hydrochloride. Parenteral heroin provided measureable blood levels of heroin, 6-acetylmorphine, and morphine. Blood levels of heroin and 6-acetylmorphine reached their maximal concentrations within minutes and were cleared rapidly. The mean half-life of heroin (+/- S.D.) after intravenous injection or infusion was only 3.0 +/- 1.3 minutes, and the mean clearance of heroin from the blood at apparent steady state was 30.8 +/- 2.1 ml per kilogram of body weight per minute. Morphine levels rose more gradually, and morphine was cleared much more slowly. Oral administration of heroin resulted in measurable blood levels of morphine but not of heroin or 6-acetylmorphine. The amount of circulating morphine provided by an oral dose of heroin was only 79 per cent of that available from an equal amount of morphine. We conclude that heroin is a pro-drug that serves to determine the distribution of its active metabolites. Parenteral heroin is rapidly converted to 6-acetylmorphine, which contributes to rapid pain relief. Oral heroin is converted to morphine and appears to be an inefficient means of providing morphine to the systemic circulation.
This article has been cited by other articles:
Kidd, S, Brennan, S, Stephen, R, Minns, R, Beattie, T
(2009). Comparison of morphine concentration-time profiles following intravenous and intranasal diamorphine in children. Arch. Dis. Child.
94: 974-978
[Abstract][Full Text]
Andersen, J. M., Ripel, A., Boix, F., Normann, P. T., Morland, J.
(2009). Increased Locomotor Activity Induced by Heroin in Mice: Pharmacokinetic Demonstration of Heroin Acting as a Prodrug for the Mediator 6-Monoacetylmorphine in Vivo. J. Pharmacol. Exp. Ther.
331: 153-161
[Abstract][Full Text]
Antonilli, L., Suriano, C., Paolone, G., Badiani, A., Nencini, P.
(2003). Repeated Exposures to Heroin and/or Cadmium Alter the Rate of Formation of Morphine Glucuronides in the Rat. J. Pharmacol. Exp. Ther.
307: 651-660
[Abstract][Full Text]
Bowen, C. A., Fischer, B. D., Mello, N. K., Negus, S. S.
(2002). Antagonism of the Antinociceptive and Discriminative Stimulus Effects of Heroin and Morphine by 3-Methoxynaltrexone and Naltrexone in Rhesus Monkeys. J. Pharmacol. Exp. Ther.
302: 264-273
[Abstract][Full Text]
Ceder, G., Jones, A. W.
(2001). Concentration Ratios of Morphine to Codeine in Blood of Impaired Drivers as Evidence of Heroin Use and not Medication with Codeine. Clin. Chem.
47: 1980-1984
[Abstract][Full Text]
Rady, J. J., Holmes, B. B., Portoghese, P. S., Fujimoto, J. M.
(2000). Morphine Tolerance in Mice Changes Response of Heroin from {micro} to {delta} Opioid Receptors. Exp. Biol. Med.
224: 93-101
[Abstract][Full Text]
Sporer, K. A.
(1999). Acute Heroin Overdose. ANN INTERN MED
130: 584-590
[Abstract][Full Text]
Gewolb, I. H., O'Brien, J., Slavin, R. E.
(1999). Opioids Accelerate Fetal Rat Lung Maturation In Vitro. Am. J. Respir. Cell Mol. Bio.
20: 511-516
[Abstract][Full Text]
Gorman, D.
(1991). Review article : Opioid analgesics in the management of pain in patients with cancer: an update. Palliat Med
5: 277-294
[Abstract]
Sherman, L. M.
(1988). The legalization of heroin: A misguided effort. AM J HOSP PALLIAT CARE
5: 13-14
Hanks, G., Hoskin, P.
(1987). Review article : Opioid analgesics in the management of pain in patients with cancer. A review. Palliat Med
1: 1-25
Levine, M. N., Sackett, D. L., Bush, H.
(1986). Heroin vs Morphine for Cancer Pain?. Arch Intern Med
146: 353-356
[Abstract]
Previous
